February 27, 2026 February 27, 2026Categories Announcements News StoriesThe February 2026 News from ECOG-ACRIN blog is now available
February 13, 2026 February 13, 2026Categories Announcements News StoriesThe Winter 2026 advocacy blog Considering Clinical Trials is now available
February 3, 2026 February 3, 2026Categories News StoriesECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations
January 31, 2026 January 31, 2026Categories Announcements News StoriesThe January 2026 News from ECOG-ACRIN blog is now available
December 22, 2025 December 22, 2025Categories Announcements News StoriesThe December 2025 News from ECOG-ACRIN blog is now available
November 21, 2025 November 21, 2025Categories Announcements News StoriesThe November 2025 News from ECOG-ACRIN blog is now available
November 3, 2025 November 3, 2025Categories News StoriesSTAMP (EA6174), the largest trial of adjuvant pembrolizumab in Merkel cell carcinoma, reports key benefit
October 30, 2025 October 30, 2025Categories News StoriesWATCH: Dr. Janice Mehnert discusses STAMP (EA6174) trial results; adjuvant pembrolizumab in resected Merkel cell carcinoma shows improved distant metastasis-free survival
